Very Late Restenosis after Paclitaxel-Eluting Stent Implantation

  1. John Cosgrave, MD;
  2. Asif Qasim, PhD;
  3. Azeem Latib, MD;
  4. Tiziana Claudia Aranzulla, MD; and
  5. Antonio Colombo, MD
  1. From Centro Cuore Columbus and San Raffaele Scientific Institute, Milan, Italy.

    Background: Late restenosis after drug-eluting stent implantation has been described for sirolimus-eluting stents (Cypher, Johnson & Johnson, Warren, New Jersey) (1–3) but not for paclitaxel-eluting stents (Taxus, Boston Scientific, Natick, Massachusetts) (4).

    Objective: To describe a patient with a paclitaxel-eluting stent who presented with late in-stent restenosis 33 months after stent placement.

    Case Report: A 76-year-old man with a history of an inferior myocardial infarction and coronary artery bypass grafting in 1989 presented to our center in April 2004 with stable angina pectoris. In 2001, he underwent bare-metal stent implantation in the saphenous vein graft to the right coronary artery, and a covered pericardium stent was placed …

    « Previous | Next Article »Table of Contents